These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 28017325

  • 1. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M, CRIC Study Investigators.
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [Abstract] [Full Text] [Related]

  • 2. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.
    BMJ Open; 2017 Aug 23; 7(8):e016528. PubMed ID: 28838895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor 23 and Inflammation in CKD.
    Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Chronic Renal Insufficiency Cohort.
    Clin J Am Soc Nephrol; 2012 Jul 23; 7(7):1155-62. PubMed ID: 22554719
    [Abstract] [Full Text] [Related]

  • 9. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
    Hanks LJ, Casazza K, Judd SE, Jenny NS, Gutiérrez OM.
    PLoS One; 2015 Jul 23; 10(3):e0122885. PubMed ID: 25811862
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J, Taliercio JT, Feldman HI, Srivastava A, Townsend RR, Cohen DL, Horwitz EJ, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, Appel LJ, Matsushita K, CRIC study Investigators.
    J Am Soc Nephrol; 2020 Aug 07; 31(8):1836-1846. PubMed ID: 32576601
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
    Westerberg PA, Tivesten Å, Karlsson MK, Mellström D, Orwoll E, Ohlsson C, Larsson TE, Linde T, Ljunggren Ö.
    BMC Nephrol; 2013 Apr 15; 14():85. PubMed ID: 23587028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV, Ritchie JP, Middleton R, Larsson A, Larsson TE, Kalra PA.
    Nephrology (Carlton); 2016 Jul 15; 21(7):566-73. PubMed ID: 27334353
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.